Sarilumab efficacy and safety in adults with early polymyalgia rheumatica

Trial Identifier: EFC18055
Sponsor: Sanofi
Collaborator:
Regeneron Pharmaceuticals
Start Date: May 2026
Primary Completion Date: June 2029
Study Completion Date: July 2029

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
UNITED STATES, Colorado Denver, Colorado, UNITED STATES, 80230
UNITED STATES, Florida Clearwater, Florida, UNITED STATES, 33765
UNITED STATES, Florida Margate, Florida, UNITED STATES, 33063
UNITED STATES, Florida Mirimar, Florida, UNITED STATES, 33027
UNITED STATES, Florida Tampa, Florida, UNITED STATES, 33614